Bourse Actualite Stock
Lyrics Songs Paroles Video



Bourse FRANCE
SRD
EUROLIST A
EUROLIST B
EUROLIST C
Marche Libre
CAC 40
SBF 120
SBF 250
MIDCAC
Bourse EUROPE
Bourse Allemagne
Bourse Angleterre
Bourse Autriche
Bourse Belgique
Bourse Danemark
Bourse Espagne
Bourse Finlande
Bourse Grece
Bourse Islande
Bourse Luxembourg
Bourse Italie
Bourse Norvege
Bourse Pologne
Bourse Portugal
Bourse Pays-Bas
Bourse Suede
Bourse Suisse

Bourse Europe Est


Accueil

Google
Recherche WWW Recherche sur Ernstrade.com

INTERCELL AG  
Austria

Intercell AG (Intercell) is an Austria-based biotechnology company that focuses on the development and manufacturing of vaccines and monoclonal antibodies for the prevention and treatment of infectious diseases. The Company’s technology platforms include an antigen-discovery system, adjuvants and a patch-based delivery system. Intercell’s portfolio consists of one marketed product, eight product candidates in clinical development and additional candidates in pre-clinical development. Its core product is a Japanese Encephalitis vaccine. The focus of the development portfolio of the Company is on nosocomial infections and other selected serious infectious diseases. Its development pipeline includes a Staphylococcus aureus vaccine (P hase II/III); Pseudomonas vaccine (Phase II), and a Pandemic Influenza patch system (Phase I/II), among others. Intercell operates in Austria, Scotland and the United States. It has partnerships with Merck & Co., Novartis, GlaxoSmithKline and sanofi-aventis. 

http://www.intercell.com/
Address
Campus Vienna Biocenter 2
Vienna, 1030
Austria
+43-1-206200 (Phone)
+43-1-20620800 (Fax)
 
 
 

 

Copyright  2011   Ernstrade.com

Bourse ETATS UNIS
Bourse NASDAQ
Bourse NYSE
Bourse ASE
Bourse Philadelphia
Bourse Boston
Bourse AMERIQUES
Bourse Bresil
Bourse Canada
Bourse Jamaique
Bourse Trinidade

Avertissement légal - Contact Webmaster - Partenaires